Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wnt proteins (Wingless-type MMTV integration site family member proteins) form a conserved family of secreted glycoproteins that act as essential signaling molecules in metazoan biology. They regulate crucial processes such as embryonic patterning, cell fate determination, proliferation, and stem cell maintenance. Wnt ligands bind at the cell surface to Frizzled family receptors and co-receptors, initiating complex intracellular pathways that control gene expression—most notably via the canonical Wnt/β-catenin pathway and several non-canonical pathways. Dysregulation of Wnt signaling is causally implicated in developmental disorders and is a major driver of cancers, especially colorectal cancer. Therapeutic targeting of the Wnt pathway is under active investigation, mainly via indirect means due to the challenging nature of directly targeting secreted Wnt ligands.
Inhibition of Wnt ligand secretion (Porcupine inhibitors); antagonism of Wnt–Frizzled binding (receptor blockers); inhibition of downstream β-catenin–mediated transcription (various small molecules and biologics).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wnt family member protein (Wnt).